^
    3ms
    AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma (clinicaltrials.gov)
    P1, N=110, Recruiting, Carna Biosciences, Inc. | Phase classification: P1b --> P1
    Phase classification
    |
    PLCG2 (Phospholipase C Gamma 2)
    |
    PLCG2 mutation
    |
    AS-1763
    12ms
    AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma (clinicaltrials.gov)
    P1b, N=110, Recruiting, Carna Biosciences, Inc. | Not yet recruiting --> Recruiting
    Enrollment open
    |
    AS-1763